Reduced effectiveness of CD4+Foxp3+regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 4940-4949

  Ellis, Jason S ^a   Hong, So Hee ^a   Zaghouani, Habib ^a   Braley Mullen, Helen ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; DRINKING WATER; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 6; THYROGLOBULIN ANTIBODY; THYROXINE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR 2; AUTOANTIBODY; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; SODIUM IODIDE; THYROGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE THYROIDITIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROSIS; IODINE ACCELERATED SPONTANEOUS AUTOIMMUNE THYROIDITIS; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; THYROID GLAND; THYROXINE BLOOD LEVEL; WILD TYPE; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED; DEFICIENCY; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; NONOBESE DIABETIC MOUSE;

ANIMALS; ANTIGENS, CD27; ANTIGENS, CD28; ANTIGENS, CD4; AUTOANTIBODIES; B-LYMPHOCYTES; FIBROSIS; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-6; LYMPHOCYTE COUNT; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SODIUM IODIDE; T-LYMPHOCYTES, REGULATORY; THYROGLOBULIN; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; THYROXINE;

EID: 84887486374     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301253     Document Type: Article

References (52)

1. Braley-Mullen, H., G. C. Sharp, B. Medling, and H. Tang. 1999. Spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J. Autoimmun. 12:157-165.
2. Rasooly, L., C. L. Burek, and N. R. Rose. 1996. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin. Immunol. Immunopathol. 81:287-292.
3. Verma, S., P. Hutchings, J. Guo, S. McLachlan, B. Rapoport, and A. Cooke. 2000. Role of MHC class I expression and CD8 (+) T cells in the evolution of iodine-induced thyroiditis in NOD-H2 (h4) and NOD mice. Eur. J. Immunol. 30:1191-1202.
4. Yu, S., B. Medling, H. Yagita, and H. Braley-Mullen. 2001. Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD. H-2h4 mice. J. Autoimmun. 16:37-46.
5. Braley-Mullen, H., and S. Yu. 2000. Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J. Immunol. 165:7262-7269.
6. Yu, S., P. K. Maiti, M. Dyson, R. Jain, and H. Braley-Mullen. 2006. B celldeficient NOD. H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J. Exp. Med. 203:349-358.
7. Yu, S., J. S. Ellis, R. Dunn, M. R. Kehry, and H. Braley-Mullen. 2012. Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adults. Int. Immunol. 24:233-242.
8. Nagayama, Y., I. Horie, O. Saitoh, M. Nakahara, and N. Abiru. 2007. CD4 +CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice. J. Autoimmun. 29:195-202.
9. Horie, I., N. Abiru, H. Sakamoto, Y. Iwakura, and Y. Nagayama. 2011. Induction of autoimmune thyroiditis by depletion of CD4+CD25+ regulatory T cells in thyroiditis-resistant IL-17, but not interferon-gamma receptor, knockout nonobese diabetic-H2h4 mice. Endocrinology. 152:4448-4454.
10. Bour-Jordan, H., and J. A. Bluestone. 2009. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol. Rev. 229:41-66.
11. Tang, Q., K. J. Henriksen, E. K. Boden, A. J. Tooley, J. Ye, S. K. Subudhi, X. X. Zheng, T. B. Strom, and J. A. Bluestone. 2003. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171:3348-3352.
12. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7:83-92.
13. Salomon, B., D. J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J. A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431-440.
14. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23:515-548.
15. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
16. Bour-Jordan, H., J. H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, and J. A. Bluestone. 2011. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol. Rev. 241:180-205.
17. Girvin, A. M., M. C. Dal Canto, L. Rhee, B. Salomon, A. Sharpe, J. A. Bluestone, and S. D. Miller. 2000. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J. Immunol. 164:136-143.
18. Tada, Y., K. Nagasawa, A. Ho, F. Morito, O. Ushiyama, N. Suzuki, H. Ohta, and T. W. Mak. 1999. CD28-deficient mice are highly resistant to collagen-induced arthritis. J. Immunol. 162:203-208.
19. Meagher, C., Q. Tang, B. T. Fife, H. Bour-Jordan, J. Wu, C. Pardoux, M. Bi, K. Melli, and J. A. Bluestone. 2008. Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J. Immunol. 180:7793-7803.
20. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455-1465.
21. Podolin, P. L., A. Pressey, N. H. DeLarato, P. A. Fischer, L. B. Peterson, and L. S. Wicker. 1993. I-E+ nonobese diabetic mice develop insulitis and diabetes. J. Exp. Med. 178:793-803.
22. Tartar, D. M., A. M. Van Morlan, X. Wan, F. B. Guloglu, R. Jain, C. L. Haymaker, J. S. Ellis, C. M. Hoeman, J. A. Cascio, M. Dhakal, et al. 2010. Foxp3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes. J. Immunol. 184:3377-3385.
23. Braley-Mullen, H., K. Chen, Y. Wei, and S. Yu. 2001. Role of TGFbeta in development of spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J. Immunol. 167:7111-7118.
24. Yu, S., G. C. Sharp, and H. Braley-Mullen. 2006. Thyroid epithelial cell hyperplasia in IFN-gamma deficient NOD. H-2h4 mice. Clin. Immunol. 118:92-100.
25. McLachlan, S. M., H. Braley-Mullen, C. R. Chen, H. Aliesky, P. N. Pichurin and B. Rapoport. 2005. Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD. H-2h4 mice. Endocrinology. 146:294-300.
26. Yu, S., R. Dunn, M. R. Kehry, and H. Braley-Mullen. 2008. B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J. Immunol. 180:7706-7713.
27. Yu, S., G. C. Sharp, and H. Braley-Mullen. 2002. Dual roles for IFN-gamma, but not for IL-4, in spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J. Immunol. 169:3999-4007.
28. Tang, H., G. C. Sharp, K. E. Peterson, and H. Braley-Mullen. 1998. Induction of granulomatous experimental autoimmune thyroiditis in IL-4 gene-disrupted mice. J. Immunol. 160:155-162.
29. Peterson, K. E., G. C. Sharp, H. Tang, and H. Braley-Mullen. 1999. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis. J. Immunol. 162:1859-1867.
30. Berndorfer, U., H. Wilms, and V. Herzog. 1996. Multimerization of thyroglobulin (TG) during extracellular storage: isolation of highly cross-linked TG from human thyroids. J. Clin. Endocrinol. Metab. 81:1918-1926.
31. Gerber, H., H. Studer, A. Conti, H. Engler, H. Kohler, and A. Haeberli. 1981. Reaccumulation of thyroglobulin and colloid in rat and mouse thyroid follicles during intense thyrotropin stimulation. A clue to the pathogenesis of colloid goiters. J. Clin. Invest. 68:1338-1347.
32. Zhang, R., A. Huynh, G. Whitcher, J. Chang, J. S. Maltzman, and L. A. Turka. 2013. An obligate cell-intrinsic function for CD28 in Tregs. J. Clin. Invest. 123:580-593.
33. Chen, X., J. J. Subleski, H. Kopf, O. M. Howard, D. N. Männel, and J. J. Oppenheim. 2008. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+Foxp3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J. Immunol. 180:6467-6471.
34. McHugh, R. S., M. J. Whitters, C. A. Piccirillo, D. A. Young, E. M. Shevach, M. Collins, and M. C. Byrne. 2002. CD4 (+) CD25 (+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:311-323.
35. +regulatory T cells in inflamed synovia. J. Exp. Med. 201:1793-1803.
36. Ahmadzadeh, M., and S. A. Rosenberg. 2006. IL-2 administration increases CD4+ CD25 (hi) Foxp3+ regulatory T cells in cancer patients. Blood. 107:2409-2414.
37. Tran, D. Q., J. Andersson, R. Wang, H. Ramsey, D. Unutmaz, and E. M. Shevach. 2009. GARP (LRRC32) is essential for the surface expression of latent TGFbeta on platelets and activated FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 106:13445-13450.
38. Ferguson, S. E., S. Han, G. Kelsoe, and C. B. Thompson. 1996. CD28 is required for germinal center formation. J. Immunol. 156:4576-4581.
39. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 261:609-612.
40. Lenschow, D. J., K. C. Herold, L. Rhee, B. Patel, A. Koons, H. Y. Qin, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity. 5:285-293.
41. Lio, C. W., L. F. Dodson, C. M. Deppong, C. S. Hsieh, and J. M. Green. 2010. CD28 facilitates the generation of Foxp3 (2) cytokine responsive regulatory T cell precursors. J. Immunol. 184:6007-6013.
42. Bouguermouh, S., G. Fortin, N. Baba, M. Rubio, and M. Sarfati. 2009. CD28 costimulation down regulates Th17 development. PLoS ONE. 4:e5087.
43. Housley, W. J., C. O. Adams, F. C. Nichols, L. Puddington, E. G. Lingenheld, L. Zhu, T. V. Rajan, and R. B. Clark. 2011. Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function. J. Immunol. 186:6779-6787.
44. Tsakiri, N., D. Papadopoulos, M. C. Denis, D. D. Mitsikostas, and G. Kollias. 2012. TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE. Eur. J. Immunol. 42:403-412.
45. Gogishvili, T., F. Lü hder, S. Goebbels, S. Beer-Hammer, K. Pfeffer, and T. Hü nig. 2013. Cell-intrinsic and -extrinsic control of Treg-cell homeostasis and function revealed by induced CD28 deletion. Eur. J. Immunol. 43:188-193.
46. Rozanski, C. H., R. Arens, L. M. Carlson, J. Nair, L. H. Boise, A. A. Chanan-Khan, S. P. Schoenberger, and K. P. Lee. 2011. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. J. Exp. Med. 208:1435-1446.
47. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23:161-196.
48. Grimaldi, C. M., D. J. Michael, and B. Diamond. 2001. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:1886-1890.
49. Wither, J. E., C. Loh, G. Lajoie, S. Heinrichs, Y. C. Cai, G. Bonventi, and R. MacLeod. 2005. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J. Immunol. 175:4309-4319.
50. Zhou, Z., H. Niu, Y. Y. Zheng, and L. Morel. 2011. Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in lupus-prone mice. BMC Immunol. 12:7.
51. Mariño, E., M. Batten, J. Groom, S. Walters, D. Liuwantara, F. Mackay, and S. T. Grey. 2008. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes. 57:395-404.
52. Njau, M. N., J. H. Kim, C. P. Chappell, R. Ravindran, L. Thomas, B. Pulendran, and J. Jacob. 2012. CD28-B7 interaction modulates short- and long-lived plasma cell function. J. Immunol. 189:2758-2767.